938
Views
11
CrossRef citations to date
0
Altmetric
Short Report

Passive protection of mice against Streptococcus pneumoniae challenge by naturally occurring and vaccine-induced human anti-PhtD antibodies

, , , , , , & show all
Pages 1836-1839 | Received 30 Jan 2015, Accepted 04 Apr 2015, Published online: 06 Jul 2015

References

  • O'Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, McCall N, Lee E, Mulholland K, Levine OS, Cherian T, et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 2009; 374:893-902; PMID:19748398; http://dx.doi.org/10.1016/S0140-6736(09)61204-6
  • Moffitt KL, Malley R. Next generation pneumococcal vaccines. Curr Opin Immunol 2011; 23:407-13; PMID:21514128; http://dx.doi.org/10.1016/j.coi.2011.04.002
  • Johnson HL, Deloria-Knoll M, Levine OS, Stoszek SK, Freimanis Hance L, Reithinger R, Muenz LR, O'Brien KL. Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project. PLoS Med. 2010: 7(10):e1000348
  • Mehr S, Wood N. Streptococcus pneumoniae–a review of carriage, infection, serotype replacement and vaccination. Paediat Respir reviews 2012; 13:258-64; PMID:23069126; http://dx.doi.org/10.1016/j.prrv.2011.12.001
  • Pittet LF, Posfay-Barbe KM. Pneumococcal vaccines for children: a global public health priority. Clin Microbiol Infect: Off Pub Eur Soc Clin Microbiol Infect Dis 2012; 18 Suppl 5:25-36; PMID:22862432; http://dx.doi.org/10.1111/j.1469-0691.2012.03938.x
  • Kallio A, Sepponen K, Hermand P, Denoel P, Godfroid F, Melin M. Role of Pht proteins in attachment of Streptococcus pneumoniae to respiratory epithelial cells. Infect Immun 2014; 82:1683-91; PMID:24491577; http://dx.doi.org/10.1128/IAI.00699-13
  • Khan MN, Pichichero ME. Vaccine candidates PhtD and PhtE of Streptococcus pneumoniae are adhesins that elicit functional antibodies in humans. Vaccine 2012; 30:2900-7; PMID:22349524; http://dx.doi.org/10.1016/j.vaccine.2012.02.023
  • Adamou JE, Heinrichs JH, Erwin AL, Walsh W, Gayle T, Dormitzer M, Dagan R, Brewah YA, Barren P, Lathigra R, et al. Identification and characterization of a novel family of pneumococcal proteins that are protective against sepsis. Infect Immun 2001; 69:949-58; PMID:11159990; http://dx.doi.org/10.1128/IAI.69.2.949-958.2001
  • Turner P, Turner C, Green N, Ashton L, Lwe E, Jankhot A, Day NP, White NJ, Nosten F, Goldblatt D. Serum antibody responses to pneumococcal colonization in the first 2 years of life: results from an SE Asian longitudinal cohort study. Clin Microbiol Infect: Off Pub Eur Soc Clin Microbiol Infect Dis 2013; 19:E551-8; PMID:24255996; http://dx.doi.org/10.1111/1469-0691.12286
  • Simell B, Ahokas P, Lahdenkari M, Poolman J, Henckaerts I, Kilpi TM, Käyhty H. Pneumococcal carriage and acute otitis media induce serum antibodies to pneumococcal surface proteins CbpA and PhtD in children. Vaccine 2009; 27:4615-21; PMID:19524618; http://dx.doi.org/10.1016/j.vaccine.2009.05.071
  • Beghetto E, Gargano N, Ricci S, Garufi G, Peppoloni S, Montagnani F, Oggioni M, Pozzi G, Felici F. Discovery of novel Streptococcus pneumoniae antigens by screening a whole-genome lambda-display library. FEMS Microbiol Lett 2006; 262:14-21; PMID:16907734; http://dx.doi.org/10.1111/j.1574-6968.2006.00360.x
  • Khan MN, Pichichero ME. CD4 T cell memory and antibody responses directed against the pneumococcal histidine triad proteins PhtD and PhtE following nasopharyngeal colonization and immunization and their role in protection against pneumococcal colonization in mice. Infect Immun 2013; 81:3781-92; PMID:23897609; http://dx.doi.org/10.1128/IAI.00313-13
  • Godfroid F, Hermand P, Verlant V, Denoel P, Poolman JT. Preclinical evaluation of the Pht proteins as potential cross-protective pneumococcal vaccine antigens. Infect Immun 2011; 79:238-45; PMID:20956575; http://dx.doi.org/10.1128/IAI.00378-10
  • Denoel P, Philipp MT, Doyle L, Martin D, Carletti G, Poolman JT. A protein-based pneumococcal vaccine protects rhesus macaques from pneumonia after experimental infection with Streptococcus pneumoniae. Vaccine 2011; 29:5495-501; PMID:21624422; http://dx.doi.org/10.1016/j.vaccine.2011.05.051
  • Seiberling M, Bologa M, Brookes R, Ochs M, Go K, Neveu D, Kamtchoua T, Lashley P, Yuan T, Gurunathan S. Safety and immunogenicity of a pneumococcal histidine triad protein D vaccine candidate in adults. Vaccine 2012; 30:7455-60; PMID:23131206; http://dx.doi.org/10.1016/j.vaccine.2012.10.080
  • Leroux-Roels G, Maes C, De Boever F, Traskine M, Ruggeberg JU, Borys D. Safety, reactogenicity and immunogenicity of a novel pneumococcal protein-based vaccine in adults: a phase I/II randomized clinical study. Vaccine 2014; 32:6838-46; PMID:24607003; http://dx.doi.org/10.1016/j.vaccine.2014.02.052
  • Leroux-Roels I, Devaster JM, Leroux-Roels G, Verlant V, Henckaerts I, Moris P, Hermand P, Van Belle P, Poolman JT, Vandepapelière P, et al. Adjuvant system AS02V enhances humoral and cellular immune responses to pneumococcal protein PhtD vaccine in healthy young and older adults: randomised, controlled trials. Vaccine 2015; 33:577-84; PMID:24176494; http://dx.doi.org/10.1016/j.vaccine.2013.10.052